Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

Recruiting

Trial locations(27 sites)

United States

Phoenix Children's Hospital, Phoenix, Arizona

Arkansas Childrens Hospital, Little Rock, Arkansas

Children's Hospital Los Angeles, Los Angeles, California

Stanford University, Palo Alto, California

University of California, Davis, Sacramento, California

University of Florida Clinical and Translational Science Institue, Gainesville, Florida

Nicklaus Children's Hospital, Miami, Florida

Nemours Children's Hospital, Orlando, Florida

Johns Hopkins All Children's Hospital, St. Petersburg, Florida

Lurie Children's Hospital of Chicago, Chicago, Illinois

Indiana University Health - Riley Hospital for Children, Indianapolis, Indiana

University of Kansas Medical Center, Kansas City, Kansas

University of Massachusetts Memorial Medical Center, North Worcester, Massachusetts

Helen DeVos Children's Hospital, Grand Rapids, Michigan

Atrium Health Neurosciences Institute, Charlotte, North Carolina

Duke University Medical Center and Childrens Health Center, Durham, North Carolina

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Penn State Milton S. Hershey Medical Center- Penn State Hershey Neuroscience Institute, Hershey, Pennsylvania

Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania

University of Texas Southwestern Medical Center, Dallas, Texas

Neurology Rare Disease Center - Neurology & Neuromuscular Care Center, Denton, Texas

The University of Texas Health Science Center at San Antonio, San Antonio, Texas

University of Virginia Health System (UVAHS) - Pediatric Neuromuscular Center, Charlottesville, Virginia

Seattle Children's Hospital, Seattle, Washington

Children's Wisconsin, Milwaukee, Wisconsin

Puerto Rico

San Jorge Children's Hospital, San Juan, Puerto Rico

FDI Clinical Research, San Juan, Puerto Rico